Insciences Organisation

Halozyme gets boost from injectable Herceptin
Roche and Halozyme are also applying the technology to a formulation of Roche's cancer drug rituximab and testing it in trials for patients with certain forms of lymphoma and leukemia. The firm's delivery tech involves the use of a recombinant enzyme ...
Halozyme Announces Positive Results from Roche's Subcutaneous Herceptin Phase ...PR Newswire (press release)

all 37 news articles »